This invention relates generally to the field of cardiopulmonary resuscitation, and in particular to techniques to increase circulation when performing CPR.
Despite current methods of CPR most people die after cardiac arrest. One of the major reasons is that blood flow to the heart and brain is very poor with traditional manual closed chest CPR. Greater circulation of blood during CPR will result in improved outcomes.
In some embodiments, methods are described for regulating gas flows into and out of a patient. According to one method, respiratory gases are repetitively forced out of the lungs. Respiratory gases are also prevented from entering back into the lungs between chest compressions. Periodically, an oxygen-containing gas is supplied to the lungs to provide ventilation.
In one particular aspect, the gases are repetitively forced out of the lungs by repetitively compressing the chest and permitting the chest to recoil a rate of about 60 to about 120 times/min. In a further aspect, a low flow and volume of oxygen is continuously supplied to the lungs. This volume of oxygen is less than the volume of respiratory gases expelled with successive chest compressions so that the number of times that the lungs are expanded with oxygen-containing gases is reduced by the low level of continuous oxygen insufflation.
Other embodiments of this invention include methods and devices for increasing circulation during CPR by reducing the volume of air in the lungs during chest compressions so that the thorax has more space to permit more blood flow into the heart with each chest compression/chest recoil cycle. Such embodiments include ways to compress the chest and allow it to recoil. During each compression, air is pushed out of the lungs through a one way valve. Every time the chest wall recoils following a compression, air (or respiratory gases) from outside the patient is prevented from passively entering the lungs. With sequential compressions, less and less air remains in the thorax. This gradual extrusion of respiratory gases from the lungs with each chest compression results in more space within the thorax (lungs, blood vessels, and heart) to be filled with blood. With more blood in the chest and less air, each time the chest is compressed more blood is ejected from the heart. After some number of compressions, such as between about 12 and about 30 (depending upon how many people are performing CPR and if the airway is secured with a face mask versus and endotracheal tube or equivalent), air is allowed to actively enter the lungs either by the delivery of a positive pressure breath from a ventilation source or by negative pressure ventilation (e.g. an iron lung or equivalent).
One advantage of such techniques is that during the chest recoil, intracranial pressures are decreased more rapidly and to a lower value, thereby further increasing the duration and magnitude of cerebral perfusion pressure.
In one particular aspect, the volume of respiratory gas expelled over a series of chest compression/recoil cycles is in the range from about 1 to about 15 cc/kg. Also, the volume of respiratory gases expelled from the chest may be expelled against a low level of fixed or variable resistance that is in the range from about 0 cm H2O to about 10 cm H2O.
In a further embodiment, the invention provides an exemplary device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest. The device comprises a housing having a rescuer port and a patient port. A valve system is disposed in the housing. Further, the housing and the valve system are configured such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port, passes through the valve system and exits the rescuer port. Also, when the chest wall recoils, oxygen containing gases are prevented from entering the lungs through the patient port by the valve system. A ventilation source may also be used to inject an oxygen-containing gas into the housing which passes through the valve system, through the patient port and to the patient to periodically expand the lungs with the oxygen-containing gases.
The valve system may be constructed using a variety of valves, such as check valves, spring valves, duck valves, electronically-controlled valves and the like. As another example, a pair of one way valves may be used that are separately configured to open with opposite gas flows passing through the housing. Also, a variety of ventilation sources may be used, such as mouth-to-mouth ventilation, a mouth-mask, a resuscitator bag, an automatic ventilator, a semi-automatic ventilator, a body cuirass, an iron-lung device and the like. In another aspect, the valve system may include a means to impede the exodus of respiratory gases from the lungs with a fixed or variable resistance that is in the range from about 0 cm H2O to about 10 cm H2O.
In one particular arrangement, at least one physiological sensor may be used to measure one or more physiological parameters. Such sensors may include electrocardiogram signal sensors, impedance sensors to detect air/blood ratio in the thorax, and the like. Also, a communication system may be employed to permit signals from the physiological sensor(s) to be transmitted to a CPR device used during resuscitation to provide various types of feedback. This can include how to perform CPR, an optimal time to actively inflate the lungs with respiratory gases, an optimal time to defibrillate, and the like. Further, timing lights may be employed to assist a rescuer in performing CPR, such as when to provide chest compressions.
In a further aspect, a supply system may be used to deliver a low flow and volume of continuous oxygen into the lungs which is less than the volume of respiratory gases expelled with successive chest compressions. In this way, the number of times that the lungs are expanded with oxygen-containing gases is reduced by the low level of continuous oxygen insufflation.
In still another embodiment, the invention provides a device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest. The device comprises a housing having a rescuer port and a patient port. Means are provided for regulating gas flows through the housing such that a volume of respiratory gas expelled from the lungs during each chest compression enters the housing through the patient port and exits the rescuer port. Also, when the chest wall recoils, oxygen containing gases are prevented from entering the lungs through the patient port. A ventilation source is employed to inject an oxygen-containing gas into the housing and to pass through the patient port and to the patient to periodically expand the lungs with the oxygen-containing gases.
In one aspect, the means for regulating gas flows comprises a pair of one way valves that are separately configured to open with opposite gas flows through the housing.
Multiple methods of chest compression may be used when performing CPR in patients in cardiac arrest. In this life-threatening situation, the heart is not capable of circulating blood so non-invasive external means are used to assist in the circulation of blood to the vital organs including the heart, lungs, and brain. The methods and devices that may be used to circulate blood during cardiac arrest include manual closed chest CPR, active compression decompression (ACD) CPR where the patient's chest is actively pulled upward (including by use of a mechanical assistance device that is adhered to the chest) to achieve complete chest wall recoil, mechanical CPR with manual or automated devices that compress the chest and either allow the chest to recoil passively or actively, and devices that compress the chest wall and then function like an iron lung and actively expand the thoracic cage. Some of these approaches and devices only compress the anterior aspect of the chest such as the sternum while other approaches and devices compress all or part of the thorax circumferentially. Some approaches and devices also compress the thorax and abdomen in an alternating sequence. Some approaches also involve compressing the lower extremities to enhance venous blood flow back to the heart and augment arterial pressure so that more blood goes to the brain. Some approaches also involve compressing the back, with the patient lying on his/her stomach. Some devices include both non-invasive methods and devices outlined above that are coupled with invasive devices, such as an intra-aortic balloon, and devices to simultaneously cool the patient
Because the cardiac valves remain essentially intact during CPR, blood is pushed out of the heart into the aorta during the chest compression phase of CPR. When the chest wall recoils, blood from extrathoracic compartments (e.g. the abdomen, upper limbs, and head) enters the thorax, specifically the heart and lungs. Without the next chest compression, the blood would pool in the heart and lungs during cardiac arrest as there is insufficient intrinsic cardiac pump activity to promote forward blood flow. Thus, chest compressions are an essential part of CPR.
During the compression phase air is pushed out of the thorax and into the atmosphere via the trachea and airways. During the decompression phase it passively returns back into the thorax via the same airway system. As such, respiratory gases move out of and back into the thorax. With each compression the pressure within the chest is nearly instantaneously transmitted to the heart and also to the brain via the spinal column and via vascular connections. Thus, with each external chest compression pressure in the thorax and within all of the organs in the thorax is increased. Application of the methods and devices described in this application, in conjunction with any of the methods of CPR noted above, result in less and less air in the thorax, making room for more and more blood to return to the heart during the chest wall recoil phase. This increases circulation to the coronary arteries and lowers intracranial pressure during the chest wall decompression phase and with each subsequent compression increases blood flow to the vital organs, especially the brain. Since the delivery of oxygen is an important aspect of CPR, periodically a positive pressure ventilation needs to be delivered to inflate the lungs and provide oxygen. The lungs can also be inflated by periodic negative pressure ventilation with, for example, an iron lung or chest cuirass device. With both positive and negative pressure ventilation, typically a patient receives a tidal volume of about 500-1000 cc during each active ventilation (positive pressure ventilation). Thus, with the practice of this invention, an equal volume of respiratory gas is extruded from lungs over the course of several compressions so that after about 2 to 6 compressions the delivered volume has been removed from the thorax and its space can be replaced by blood that refills the thoracic space. This exchange is made possible by the fact that pressures within the thorax are transduced from one organ to another nearly instantaneously. This pressure transfer occurs between different thoracic compartments, for example the lungs and the right heart, very rapidly, especially between organs in the thorax with a high degree of compliance. For example, positive pressures are transferred during the compression phase from the lungs to the right heart, and as such right heart pressures are markedly increased with each chest compression. The increase in pressure within the lungs is transferred to the heart, propelling blood within the heart chambers in a forward direction along the course from right atrium to right ventricle to pulmonary artery pulmonary vein, left ventricle, and out the aorta. The inverse is also true, with chest wall recoil the negative pressures are transmitted throughout the thorax, including the spinal cord. This pulls blood into the heart and lungs from outside the thorax. The decreases in pressures within the thorax are augmented by the methods and devices described herein. The more gas that is pushed out of the lungs with each compression and not allowed back in, the more space is made available for blood to flow into the organs within the thorax each time the chest wall recoils. The volume of respiratory gas that is expelled over a series of chest compression/recoil cycles may be about 5 to about 15 cc/kg. It would typically be expelled after about 2 to 6 compression/recoil cycles. The volume of air expelled from the chest could be expelled against a low level of fixed or variable resistance, typically in the range from about 0 cm H2O to about 10 cm H2O. This could be adjustable and could be provided by a valving system or other means having a low flow of positive pressure gases, such as oxygen. This process can be further augmented by active compressions and active decompressions. This process can also be further augmented by actively extracting a volume of respiratory gases between positive pressure breaths, creating even more space in the thorax to be filled with blood with each decompression phase of CPR to prime the heart for the next compression.
Periodically the lungs need to be inflated so that the pulmonary vascular resistance (blood pressure in the blood vessels in the lungs) does not get too high (which happens when the lungs are empty and collapse) which would limit blood flow through the lungs. Periodic inflation of the lungs also provides oxygen and helps to clear carbon dioxide. This process is depicted graphically in
A variety of valves may be coupled to the patient's airway to permit respiratory gases to escape from the lungs during chest compressions, while permitting periodic ventilation. One type of valve could be a one-way valve, typically used in combination with another one-way valve that opens in the opposite direction and which is biased in the closed position so that gases cannot enter the lungs during chest recoil or chest decompression. Another valve system that may be used is described in U.S. Pat. Nos. 5,692,498; 6,062,219; 6,526,973; and 6,604,523, incorporated herein by reference. With such valves, the threshold cracking pressure could be set high enough so that respiratory gases were always prevented from entering into the lungs until actively ventilated.
Airflow into and out of the chest through one embodiment of the invention is shown schematically in
In some cases, the patient may begin to breathe or gasp spontaneously. As shown in
The invention may employ a variety of techniques to enhance circulation. For example, a device to augment circulation during the performance of cardiopulmonary resuscitation in a patient in cardiac arrest may be configured to allow a volume of respiratory gas from the lungs to exit the airway with each external chest compression but prevents oxygen containing gases from passively reentering the lungs each time the chest wall recoils. This may be done using a valve system having a one-way valve and a means to periodically expand the lungs with oxygen-containing gases. Such a device may be particularly useful when the chest is compressed and allowed to recoil at a rate of about 60 to about 120 times/min. Such a device may also permit a volume of respiratory gases to be expelled from the lungs with each compression. Such a device can be used with manual CPR, ACD CPR, manually operated CPR devices, or automated CPR devices. With each chest wall recoil, respiratory gases are prevented from returning to the lungs by means of a one-way valve. Over each successive chest compression/chest recoil cycle there is a successive decrease in respiratory gases within the lungs. Periodically, the lungs are actively expanded with oxygen-containing gas.
The valve system can be made of one or more check valves, spring valves, duck valves, other mechanical or electronically controlled valves and switches. The lungs are periodically expanded by a ventilation source that could include: mouth-mouth ventilation, mouth-mask, a resuscitator bag, an automatic or semi-automatic ventilator, a body cuirass or iron-lung like device or the like. A variety of sensors could be incorporated into the system to guide the ventilation rate and/or determine the degree of chest compression and/or degree of chest wall recoil including: airway pressure sensors, carbon dioxide sensors, and/or impedance sensors to detect air/blood ratio in the thorax to help guide ventilation and compression rate.
The valve system could include a one-way valve with a means to impede exhalation or the exodus of respiratory gases with a fixed or variable resistance. This could be in the range from about 0 to about 20 cm H2O, and in some cases about 0 to about 10 cm H20. This may also be adjustable. In some cases such expiratory resistance helps to push blood out of the lungs back into the left heart, and serves as a means to help prevent buildup of blood in the lungs during CPR.
One particular embodiment of a valve system 20 is shown in
As shown in
Port 28 may be coupled to a patient interface 21, which could include a facial mask, endotracheal tube, other airway device or any of the other interfaces described herein. Port 26 may be coupled to a ventilation source 23, such as a ventilator bag, ventilator, tube for performing mouth-to-mouth resuscitation, or any of the other devices described herein.
Further, a controller 25 may be employed to control any of the electronic equipment. Controller 25 may include a storage device, such as memory, one or more processors and appropriate hardware and/or software for performing operations under the direction of the processor. For example, if ventilation source 23 were a ventilator, controller 25 may be employed to control operation of the ventilator. One or more sensors 27 may be coupled to controller to monitor various physiological parameters of the patient as described herein. Also, controller 25 could modify application of chest compressions and/or ventilations based on the sensed parameters.
Controller 25 may also be coupled to one or more timing lights 29 which could be used to indicate to a rescuer as to when to provide chest compressions and/or ventilations.
In
Any of the valve systems described herein could also include or be associated with physiological sensors, timing lights, impedance sensors to detect air/blood ratio in the thorax, and a way to communicate with a CPR device or other apparatus used during resuscitation (e.g. defibrillator) to provide feedback in terms of how to perform CPR, the optimal time to actively inflate the lungs with respiratory gases or the optimal time to defibrillate.
The valve systems or associated devices could also include a way to deliver a low flow and volume of continuous oxygen into the lungs which is less than or just equal to the total volume of the expelled volume of respiratory gases with chest compressions so that the number of times that the lungs are expanded with oxygen-rich gases is reduced by the low level of continuous oxygen insufflation.
One exemplary method for controlling gas flow into and out of a patient's lungs is illustrated in
For a plurality of chest recoils, respiratory gases are prevented from returning to the lungs such that over successive chest compression/chest recoil cycles there is a successive decrease in respiratory gases within the lungs (see step 42). This allows more blood to enter the thoracic space (the volume of respiratory gas expelled over a series of chest compression/recoil cycles optionally being in the range from about 4 to about 15 cc/kg). Hence, over each successive chest compression/chest recoil cycle there is a successive decrease in respiratory gases within the lungs thereby allowing more blood to enter the thoracic space.
Periodically, the patient may be ventilated (see step 46), such as by periodically actively expanding the lungs with an oxygen-containing gas. During the chest recoil phase of CPR, intracranial pressures are decreased more rapidly and to a lower value thereby further increasing the duration and magnitude of cerebral perfusion pressure. Optionally, the volume of respiratory gas expelled from the chest may be expelled against a low level of fixed or variable resistance that is in the range from about 0 to about 10 cm H2O (see step 48).
The devices and methods described herein may be used with any type of CPR technique that involves manipulation of the chest to change pressures within the thorax would benefit from this improved method of invention. Also, the method for providing periodic expansion of the lungs could include mouth-mouth ventilation, a resuscitator bag, an automatic or semi-automatic ventilator, a body cuirass or iron-lung like device. The method could also include a way to deliver a low flow and volume of continuous oxygen into the lungs which is less than the total volume of the expelled volume of respiratory gases so that the frequency of positive pressure ventilations by an external ventilation source could be reduced by the low level of continuous oxygen insufflation (see step 50).
A variety of sensors could be used to guide the periodic ventilation rate or determine the degree of chest compression or degree of chest wall recoil. Sensors could include airway pressure sensors, timing lights, carbon dioxide sensor, electrocardiogram signal sensors, and/or impedance sensors to detect air/blood ratio in the thorax to help guide ventilation and compression rate and determine if CPR should be continued, the optimal time and way to defibrillate, and when to stop CPR efforts because of futility.
The method could include a number of different airway adjuncts to maintain a seal between the trachea and the ventilation source or pharynx and ventilation source or mouth and ventilation source (e.g. endotracheal tube, face mask, laryngeal mask airway, supraglottic airway, and the like). Sensors within these airways could be used to verify proper airway adjunct placement. Such sensors could include a carbon dioxide detector which could be housed in a manner that is protected from bodily fluids.
The method could include a means to transmit the amount of respiratory gas volume delivered or expelled from the chest to a monitoring system that could be used as part of a closed loop circuit to maximize the number of compressions interspersed between active ventilations in order to maximize circulation during CPR. Circulation during CPR could be measured by a variety of means including measurement of end tidal carbon dioxide, the change in expired end tidal carbon dioxide levels over a given time interval, a change in impedance within the body, and changes in other physiological parameters such as temperature.
In some embodiments, the invention provides the ability to utilize one or more sensors that are associated with the valve systems described herein to indirectly measure the rate and depth of chest compression. For instance, the sensors may measure the respiratory gases (also referred to as “air”) delivered to the patient, the airway pressure and the like, and then used to estimate the rate and depth of chest compression. This provides a convenient way to measure the quality of CPR. This may be done, for example, by comparing variations in amount of air delivered (or airway pressure) produced by positive-pressure ventilation to the air expelled (or airway pressure variations) produced during chest compressions. This provides an easy way to monitor, analyze and report the depth of compressions, particularly to the user in real time. This feedback allows the user an opportunity to continuously adjust or change the depth of manual (or automatic) compressions to achieve a targeted depth of compressions. Also, the pressure or volume of air generated by positive-pressure ventilation or delivered by a manual resuscitation bag can be analyzed and reported to the caregiver for monitoring and adjustment purposes. In addition to calculations which report actual compression depth and breathing pressure, the frequency and duration of both breaths and compressions can be monitored and reported to the user. Hence, frequency of compressions and ventilation can be controlled to provide a targeted frequency or rate.
As one example, measurements may be taken using one or more sensors disposed anywhere within valve system 20, such as within the housing or one of the valves. For example, a sensor could be disposed in inspiration interface housing 22 or in patient interface housing 24. As another option, the sensor could be positioned within ventilation source port 26, or within one-way check valves 32 or 34. Pressure or air volume measurements may be transmitted to a controller, such as controller 25, either wirelessly or by a wired connection. Controller 25 may be programmed to determine the depth of chest compressions, timing, frequency, and the like, as described above using the pressure or air volume readings. Further, various visual and/or audio signals may be provided to the rescuer giving feedback as to depth or compressions, rate of compressions, rate of ventilation and the like. Controller 25 may be programmed to provide this feedback, such as to timing lights, computer display screens, speakers, and the like.
The invention has now been described in detail for purposes of clarity and understanding. However, it will be appreciated that certain changes and modifications may be practiced within the scope of the appended claims.
This application is a continuation of U.S. patent application Ser. No. 13/411,230, now U.S. Pat. No. 8,985,098, filed Mar. 2, 2012, which is a continuation in-part of U.S. patent application Ser. No. 11/871,879, now U.S. Pat. No. 8,151,790, filed Oct. 12, 2007, which claims the benefit of U.S. Provisional Application No. 60/912,891, filed Apr. 19, 2007, the complete disclosures of which are herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1848232 | Swope et al. | Mar 1932 | A |
2325049 | Frye et al. | Jul 1943 | A |
2774346 | Halliburton | Dec 1956 | A |
2854982 | Pagano | Oct 1958 | A |
2904898 | Marsden | Sep 1959 | A |
3009266 | Brook | Nov 1961 | A |
3049811 | Ruben | Aug 1962 | A |
3068590 | Padellford | Dec 1962 | A |
3077884 | Batrow et al. | Feb 1963 | A |
3191596 | Bird et al. | Jun 1965 | A |
3199225 | Robertson et al. | Aug 1965 | A |
3209469 | James | Oct 1965 | A |
3216413 | Mota | Nov 1965 | A |
3274705 | Breakspear | Sep 1966 | A |
3276147 | Padellford | Oct 1966 | A |
3307541 | Hewson | Mar 1967 | A |
3357426 | Cohen | Dec 1967 | A |
3420232 | Bickford | Jan 1969 | A |
3459216 | Bloom et al. | Aug 1969 | A |
3467092 | Bird et al. | Sep 1969 | A |
3509899 | Hewson | May 1970 | A |
3515163 | Freeman | Jun 1970 | A |
3523529 | Kissen | Aug 1970 | A |
3552390 | Muller | Jan 1971 | A |
3562924 | Baerman et al. | Feb 1971 | A |
3562925 | Baermann et al. | Feb 1971 | A |
3568333 | Clark | Mar 1971 | A |
3662751 | Barkalow et al. | May 1972 | A |
3669108 | Sundblom et al. | Jun 1972 | A |
3734100 | Walker et al. | May 1973 | A |
3739776 | Bird et al. | Jun 1973 | A |
3794043 | McGinnis | Feb 1974 | A |
3815606 | Mazal | Jun 1974 | A |
3834383 | Weigl et al. | Sep 1974 | A |
3872609 | Smrcka | Mar 1975 | A |
3874093 | Garbe | Apr 1975 | A |
3875626 | Tysk et al. | Apr 1975 | A |
3933171 | Hay | Jan 1976 | A |
3949388 | Fuller | Apr 1976 | A |
3973564 | Carden | Aug 1976 | A |
3981398 | Boshoff | Sep 1976 | A |
3993059 | Sjostrand | Nov 1976 | A |
4037595 | Elam | Jul 1977 | A |
4041943 | Miller | Aug 1977 | A |
4054134 | Kritzer | Oct 1977 | A |
4077400 | Harrigan | Mar 1978 | A |
4077404 | Elam | Mar 1978 | A |
4095590 | Harrigan | Jun 1978 | A |
4166458 | Harrigan | Sep 1979 | A |
4193406 | Jinotti | Mar 1980 | A |
4198963 | Barkalow | Apr 1980 | A |
4226233 | Kritzer | Oct 1980 | A |
4237872 | Harrigan | Dec 1980 | A |
4240419 | Furlong et al. | Dec 1980 | A |
4259951 | Chernack et al. | Apr 1981 | A |
4262667 | Grant | Apr 1981 | A |
4297999 | Kitrell | Nov 1981 | A |
4298023 | McGinnis | Nov 1981 | A |
4316458 | Hammerton-Fraser | Feb 1982 | A |
4320754 | Watson et al. | Mar 1982 | A |
4326507 | Barkalow | Apr 1982 | A |
4331426 | Sweeney | May 1982 | A |
4349015 | Alferness | Sep 1982 | A |
4360345 | Hon | Nov 1982 | A |
4397306 | Weisfeldt | Aug 1983 | A |
4424806 | Newman et al. | Jan 1984 | A |
4446864 | Watson et al. | May 1984 | A |
4448192 | Stawitcke et al. | May 1984 | A |
4449526 | Elam | May 1984 | A |
4481938 | Lindley | Nov 1984 | A |
4501582 | Schulz | Feb 1985 | A |
4513737 | Mabuchi | Apr 1985 | A |
4519388 | Schwanbom et al. | May 1985 | A |
4520811 | White et al. | Jun 1985 | A |
4533137 | Sonne | Aug 1985 | A |
4543951 | Phuc | Oct 1985 | A |
4588383 | Parker et al. | May 1986 | A |
4598706 | Darowski et al. | Jul 1986 | A |
4601465 | Roy | Jul 1986 | A |
4602653 | Ruiz-Vela et al. | Jul 1986 | A |
4637386 | Baum | Jan 1987 | A |
4738249 | Linman et al. | Apr 1988 | A |
4774941 | Cook | Oct 1988 | A |
4797104 | Laerdal et al. | Jan 1989 | A |
4807638 | Sramek | Feb 1989 | A |
4809683 | Hanson | Mar 1989 | A |
4827935 | Geddes et al. | May 1989 | A |
4828501 | Ingenito et al. | May 1989 | A |
4863385 | Pierce | Sep 1989 | A |
4881527 | Lerman | Nov 1989 | A |
4898166 | Rose et al. | Feb 1990 | A |
4898167 | Pierce et al. | Feb 1990 | A |
4928674 | Halperin et al. | May 1990 | A |
4932879 | Ingenito et al. | Jun 1990 | A |
4971042 | Lerman | Nov 1990 | A |
4971051 | Toffolon | Nov 1990 | A |
4984987 | Brault et al. | Jan 1991 | A |
5014698 | Cohen | May 1991 | A |
5016627 | Dahrendorf et al. | May 1991 | A |
5029580 | Radford et al. | Jul 1991 | A |
5042500 | Norlien et al. | Aug 1991 | A |
5050593 | Poon | Sep 1991 | A |
5056505 | Warwick et al. | Oct 1991 | A |
5083559 | Brault et al. | Jan 1992 | A |
5109840 | Daleiden | May 1992 | A |
5119825 | Huhn | Jun 1992 | A |
5150291 | Cummings et al. | Sep 1992 | A |
5163424 | Kohnke | Nov 1992 | A |
5183038 | Hoffman et al. | Feb 1993 | A |
5184620 | Cudahy et al. | Feb 1993 | A |
5188098 | Hoffman et al. | Feb 1993 | A |
5193529 | Labaere | Mar 1993 | A |
5193544 | Jaffe | Mar 1993 | A |
5195896 | Sweeney et al. | Mar 1993 | A |
5217006 | McCulloch | Jun 1993 | A |
5231086 | Sollevi | Jul 1993 | A |
5235970 | Augustine | Aug 1993 | A |
5238409 | Brault et al. | Aug 1993 | A |
5239988 | Swanson | Aug 1993 | A |
5263476 | Henson | Nov 1993 | A |
5265595 | Rudolph | Nov 1993 | A |
5282463 | Hammersley | Feb 1994 | A |
5295481 | Geeham | Mar 1994 | A |
5301667 | McGrail et al. | Apr 1994 | A |
5305743 | Brain | Apr 1994 | A |
5306293 | Zacouto | Apr 1994 | A |
5312259 | Flynn | May 1994 | A |
5313938 | Garfield | May 1994 | A |
5316907 | Lurie et al. | May 1994 | A |
5330514 | Egelandsdal et al. | Jul 1994 | A |
5335654 | Rapoport | Aug 1994 | A |
5353788 | Miles | Oct 1994 | A |
5355879 | Brain | Oct 1994 | A |
5359998 | Lloyd | Nov 1994 | A |
5366231 | Hung | Nov 1994 | A |
5377671 | Biondi et al. | Jan 1995 | A |
5383786 | Kohnke | Jan 1995 | A |
5388575 | Taube | Feb 1995 | A |
5392774 | Sato | Feb 1995 | A |
5395399 | Rosenwald | Mar 1995 | A |
5397237 | Dhont et al. | Mar 1995 | A |
5398714 | Price | Mar 1995 | A |
5413110 | Cummings et al. | May 1995 | A |
5423685 | Adamson et al. | Jun 1995 | A |
5423772 | Lurie et al. | Jun 1995 | A |
5425742 | Joy | Jun 1995 | A |
5437272 | Fuhrman | Aug 1995 | A |
5452715 | Boussignac | Sep 1995 | A |
5454779 | Lurie | Oct 1995 | A |
5458562 | Cooper | Oct 1995 | A |
5468151 | Egelandsdal et al. | Nov 1995 | A |
5474533 | Ward et al. | Dec 1995 | A |
5477860 | Essen-Moller | Dec 1995 | A |
5490820 | Schock et al. | Feb 1996 | A |
5492115 | Abramov et al. | Feb 1996 | A |
5492116 | Scarberry et al. | Feb 1996 | A |
5496257 | Kelly | Mar 1996 | A |
5517986 | Starr et al. | May 1996 | A |
5544648 | Fischer, Jr. | Aug 1996 | A |
5549106 | Gruenke et al. | Aug 1996 | A |
5549581 | Lurie et al. | Aug 1996 | A |
5551420 | Lurie et al. | Sep 1996 | A |
5557049 | Ratner | Sep 1996 | A |
5580255 | Flynn | Dec 1996 | A |
5582182 | Hillsman | Dec 1996 | A |
5588422 | Lurie et al. | Dec 1996 | A |
5593306 | Kohnke | Jan 1997 | A |
5614490 | Przybelski | Mar 1997 | A |
5617844 | King | Apr 1997 | A |
5618665 | Lurie et al. | Apr 1997 | A |
5619665 | Emma | Apr 1997 | A |
5628305 | Melker | May 1997 | A |
5632298 | Artinian | May 1997 | A |
5643231 | Lurie et al. | Jul 1997 | A |
5645522 | Lurie et al. | Jul 1997 | A |
5657751 | Karr, Jr. | Aug 1997 | A |
5678535 | DiMarco | Oct 1997 | A |
5685298 | Idris | Nov 1997 | A |
5692498 | Lurie et al. | Dec 1997 | A |
5697364 | Chua et al. | Dec 1997 | A |
5701883 | Hete et al. | Dec 1997 | A |
5701889 | Danon | Dec 1997 | A |
5704346 | Inoue | Jan 1998 | A |
5720282 | Wright | Feb 1998 | A |
5722963 | Lurie et al. | Mar 1998 | A |
5730122 | Lurie | Mar 1998 | A |
5735876 | Kroll et al. | Apr 1998 | A |
5738637 | Kelly et al. | Apr 1998 | A |
5743864 | Baldwin, II | Apr 1998 | A |
5782883 | Kroll et al. | Jul 1998 | A |
5794615 | Estes | Aug 1998 | A |
5806512 | Abramov et al. | Sep 1998 | A |
5814086 | Hirschberg et al. | Sep 1998 | A |
5817997 | Wernig | Oct 1998 | A |
5823185 | Chang | Oct 1998 | A |
5823787 | Gonzalez et al. | Oct 1998 | A |
5827893 | Lurie et al. | Oct 1998 | A |
5832920 | Field | Nov 1998 | A |
5853292 | Eggert et al. | Dec 1998 | A |
5881725 | Hoffman et al. | Mar 1999 | A |
5885084 | Pastrick et al. | Mar 1999 | A |
5891062 | Schock et al. | Apr 1999 | A |
5896857 | Hely et al. | Apr 1999 | A |
5916165 | Duchon et al. | Jun 1999 | A |
5919210 | Lurie et al. | Jul 1999 | A |
5927273 | Federowicz et al. | Jul 1999 | A |
5937853 | Strom | Aug 1999 | A |
5941710 | Lampotang et al. | Aug 1999 | A |
5975081 | Hood et al. | Nov 1999 | A |
5977091 | Nieman et al. | Nov 1999 | A |
5984909 | Lurie et al. | Nov 1999 | A |
5988166 | Hayek | Nov 1999 | A |
6001085 | Lurie et al. | Dec 1999 | A |
6010470 | Albery et al. | Jan 2000 | A |
6029667 | Lurie | Feb 2000 | A |
6042532 | Freed et al. | Mar 2000 | A |
6062219 | Lurie et al. | May 2000 | A |
6078834 | Lurie et al. | Jun 2000 | A |
6086582 | Altman et al. | Jul 2000 | A |
6123074 | Hete et al. | Sep 2000 | A |
6131571 | Lampotang et al. | Oct 2000 | A |
6155257 | Lurie et al. | Dec 2000 | A |
6155647 | Albecker, III | Dec 2000 | A |
6165105 | Boutellier et al. | Dec 2000 | A |
6167879 | Sievers et al. | Jan 2001 | B1 |
6174295 | Cantrell et al. | Jan 2001 | B1 |
6176237 | Wunderlich et al. | Jan 2001 | B1 |
6193519 | Eggert et al. | Feb 2001 | B1 |
6209540 | Sugiura et al. | Apr 2001 | B1 |
6224562 | Lurie et al. | May 2001 | B1 |
6234916 | Carusillo et al. | May 2001 | B1 |
6234985 | Lurie et al. | May 2001 | B1 |
6277107 | Lurie | Aug 2001 | B1 |
6296490 | Bowden | Oct 2001 | B1 |
6312399 | Lurie et al. | Nov 2001 | B1 |
6334441 | Zowtiak et al. | Jan 2002 | B1 |
6356785 | Snyder et al. | Mar 2002 | B1 |
6374827 | Bowden et al. | Apr 2002 | B1 |
6390996 | Halperin | May 2002 | B1 |
6425393 | Lurie et al. | Jul 2002 | B1 |
6439228 | Hete et al. | Aug 2002 | B1 |
6459933 | Lurie et al. | Oct 2002 | B1 |
6463327 | Lurie et al. | Oct 2002 | B1 |
6486206 | Lurie | Nov 2002 | B1 |
6526970 | DeVries et al. | Mar 2003 | B2 |
6526973 | Lurie et al. | Mar 2003 | B1 |
6536432 | Truschel | Mar 2003 | B2 |
6544172 | Toeppen-Sprigg | Apr 2003 | B2 |
6555057 | Barbut et al. | Apr 2003 | B1 |
6578574 | Kohnke | Jun 2003 | B1 |
6584973 | Biondi et al. | Jul 2003 | B1 |
6587726 | Lurie et al. | Jul 2003 | B2 |
6595213 | Bennarsten | Jul 2003 | B2 |
6604523 | Lurie et al. | Aug 2003 | B2 |
6622274 | Lee et al. | Sep 2003 | B1 |
6631716 | Robinson et al. | Oct 2003 | B1 |
6656166 | Lurie et al. | Dec 2003 | B2 |
6662032 | Gavish et al. | Dec 2003 | B1 |
6676613 | Cantrell et al. | Jan 2004 | B2 |
6729334 | Baran | May 2004 | B1 |
6758217 | Younes | Jul 2004 | B1 |
6776156 | Lurie et al. | Aug 2004 | B2 |
6780017 | Pastrick et al. | Aug 2004 | B2 |
6792947 | Bowden | Sep 2004 | B1 |
6863656 | Lurie | Mar 2005 | B2 |
6877511 | DeVries et al. | Apr 2005 | B2 |
6935336 | Lurie et al. | Aug 2005 | B2 |
6938618 | Lurie et al. | Sep 2005 | B2 |
6986349 | Lurie | Jan 2006 | B2 |
6988499 | Holt et al. | Jan 2006 | B2 |
7011622 | Kuyava et al. | Mar 2006 | B2 |
7032596 | Thompson et al. | Apr 2006 | B2 |
7044128 | Lurie et al. | May 2006 | B2 |
7066173 | Banner et al. | Jun 2006 | B2 |
7082945 | Lurie | Aug 2006 | B2 |
7096866 | Be'eri et al. | Aug 2006 | B2 |
7174891 | Lurie et al. | Feb 2007 | B2 |
7185649 | Lurie | Mar 2007 | B2 |
7188622 | Martin et al. | Mar 2007 | B2 |
7195012 | Lurie | Mar 2007 | B2 |
7195013 | Lurie | Mar 2007 | B2 |
7204251 | Lurie | Apr 2007 | B2 |
7210480 | Lurie et al. | May 2007 | B2 |
7220235 | Geheb et al. | May 2007 | B2 |
7226427 | Steen | Jun 2007 | B2 |
7275542 | Lurie et al. | Oct 2007 | B2 |
7311668 | Lurie | Dec 2007 | B2 |
7469700 | Baran | Dec 2008 | B2 |
7487773 | Li | Feb 2009 | B2 |
7500481 | Delache et al. | Mar 2009 | B2 |
7594508 | Doyle | Sep 2009 | B2 |
7650181 | Freeman et al. | Jan 2010 | B2 |
7682312 | Lurie | Mar 2010 | B2 |
7766011 | Lurie | Aug 2010 | B2 |
7793659 | Breen | Sep 2010 | B2 |
7836881 | Lurie et al. | Nov 2010 | B2 |
7899526 | Benditt et al. | Mar 2011 | B2 |
8011367 | Lurie et al. | Sep 2011 | B2 |
8108204 | Gabrilovich et al. | Jan 2012 | B2 |
8151790 | Lurie et al. | Apr 2012 | B2 |
8210176 | Metzger et al. | Jul 2012 | B2 |
8287474 | Koenig et al. | Oct 2012 | B1 |
8388682 | Hendricksen et al. | Mar 2013 | B2 |
8408204 | Lurie | Apr 2013 | B2 |
8702633 | Voss et al. | Apr 2014 | B2 |
8755902 | Lurie et al. | Jun 2014 | B2 |
8939922 | Strand et al. | Jan 2015 | B2 |
20010003984 | Bennarsten et al. | Jun 2001 | A1 |
20010029339 | Orr et al. | Oct 2001 | A1 |
20010047140 | Freeman | Nov 2001 | A1 |
20020007832 | Doherty | Jan 2002 | A1 |
20020069878 | Lurie et al. | Jun 2002 | A1 |
20020104544 | Ogushi et al. | Aug 2002 | A1 |
20020170562 | Lurie et al. | Nov 2002 | A1 |
20020179090 | Boussignac | Dec 2002 | A1 |
20030000526 | Gobel | Jan 2003 | A1 |
20030037784 | Lurie | Feb 2003 | A1 |
20030062040 | Lurie et al. | Apr 2003 | A1 |
20030062041 | Keith et al. | Apr 2003 | A1 |
20030192547 | Lurie et al. | Oct 2003 | A1 |
20040016428 | Lurie | Jan 2004 | A9 |
20040058305 | Lurie et al. | Mar 2004 | A1 |
20040200473 | Lurie et al. | Oct 2004 | A1 |
20040200474 | Lurie | Oct 2004 | A1 |
20040210281 | Dzeng et al. | Oct 2004 | A1 |
20040211415 | Lurie | Oct 2004 | A1 |
20040211416 | Lurie | Oct 2004 | A1 |
20040211417 | Lurie | Oct 2004 | A1 |
20040231664 | Lurie et al. | Nov 2004 | A1 |
20040267325 | Geheb et al. | Dec 2004 | A1 |
20050016534 | Ost | Jan 2005 | A1 |
20050075531 | Loeb et al. | Apr 2005 | A1 |
20050126567 | Lurie | Jun 2005 | A1 |
20050165334 | Lurie | Jul 2005 | A1 |
20050199237 | Lurie | Sep 2005 | A1 |
20050217677 | Lurie et al. | Oct 2005 | A1 |
20050267381 | Benditt et al. | Dec 2005 | A1 |
20060089574 | Paradis | Apr 2006 | A1 |
20060129191 | Sullivan et al. | Jun 2006 | A1 |
20060270952 | Freeman et al. | Nov 2006 | A1 |
20070017523 | Be-Eri et al. | Jan 2007 | A1 |
20070021683 | Benditt et al. | Jan 2007 | A1 |
20070199566 | Be'eri | Aug 2007 | A1 |
20070221222 | Lurie | Sep 2007 | A1 |
20070277826 | Lurie | Dec 2007 | A1 |
20080039748 | Palmer et al. | Feb 2008 | A1 |
20080047555 | Lurie et al. | Feb 2008 | A1 |
20080092891 | Cewers | Apr 2008 | A1 |
20080097258 | Walker | Apr 2008 | A1 |
20080097385 | Vinten-Johansen et al. | Apr 2008 | A1 |
20080108905 | Lurie | May 2008 | A1 |
20080255482 | Lurie | Oct 2008 | A1 |
20080257344 | Lurie et al. | Oct 2008 | A1 |
20090020128 | Metzger et al. | Jan 2009 | A1 |
20090062701 | Yannopoulos et al. | Mar 2009 | A1 |
20090076573 | Burnett et al. | Mar 2009 | A1 |
20090164000 | Shirley | Jun 2009 | A1 |
20090277447 | Voss et al. | Nov 2009 | A1 |
20090299156 | Simpson et al. | Dec 2009 | A1 |
20100000535 | Wickham et al. | Jan 2010 | A1 |
20100179442 | Lurie | Jul 2010 | A1 |
20100319691 | Lurie et al. | Dec 2010 | A1 |
20110056491 | Rumph et al. | Mar 2011 | A1 |
20110098612 | Lurie | Apr 2011 | A1 |
20110160782 | Lurie et al. | Jun 2011 | A1 |
20110201979 | Voss et al. | Aug 2011 | A1 |
20110297147 | Lick et al. | Dec 2011 | A1 |
20120016279 | Banville et al. | Jan 2012 | A1 |
20120203147 | Lurie et al. | Aug 2012 | A1 |
20120302908 | Hemnes et al. | Nov 2012 | A1 |
20120330199 | Lurie et al. | Dec 2012 | A1 |
20120330200 | Voss et al. | Dec 2012 | A1 |
20130118498 | Robitaille et al. | May 2013 | A1 |
20130172768 | Lehman | Jul 2013 | A1 |
20130231593 | Yannopoulos et al. | Sep 2013 | A1 |
20130269701 | Lurie | Oct 2013 | A1 |
20140005566 | Homuth et al. | Jan 2014 | A1 |
20140048061 | Yannopoulos et al. | Feb 2014 | A1 |
Number | Date | Country |
---|---|---|
1487792 | Oct 1992 | AU |
60539 | Nov 1994 | AU |
687942 | May 1995 | AU |
668771 | Aug 1963 | CA |
2077608 | Mar 1993 | CA |
2214887 | Jul 2008 | CA |
1183731 | Jun 1998 | CN |
2453490 | May 1975 | DE |
4308493 | Sep 1994 | DE |
0029352 | May 1981 | EP |
0139363 | May 1985 | EP |
0245142 | Nov 1987 | EP |
0367285 | May 1990 | EP |
0411714 | Feb 1991 | EP |
0509773 | Oct 1992 | EP |
0560440 | Sep 1993 | EP |
0623033 | Nov 1994 | EP |
1344862 | Jan 1974 | GB |
1465127 | Feb 1977 | GB |
2117250 | Oct 1983 | GB |
2139099 | Nov 1984 | GB |
2005000675 | Jan 2005 | JP |
2006524543 | Nov 2006 | JP |
2007504859 | Mar 2007 | JP |
9005518 | May 1990 | WO |
9302439 | Feb 1993 | WO |
9321982 | Nov 1993 | WO |
9426229 | Nov 1994 | WO |
9513108 | May 1995 | WO |
9528193 | Oct 1995 | WO |
9628215 | Sep 1996 | WO |
9820938 | May 1998 | WO |
9947197 | Sep 1999 | WO |
9963926 | Dec 1999 | WO |
0020061 | Apr 2000 | WO |
0102049 | Jan 2001 | WO |
0170092 | Sep 2001 | WO |
0170332 | Sep 2001 | WO |
02092169 | Nov 2002 | WO |
2004096109 | Nov 2004 | WO |
2006088373 | Aug 2006 | WO |
2008147229 | Dec 2008 | WO |
2010044034 | Apr 2010 | WO |
2013064888 | May 2013 | WO |
2013096495 | Jun 2013 | WO |
2014026193 | Feb 2014 | WO |
Entry |
---|
US 5,584,866, 12/1996, Kroll et al. (withdrawn) |
Advanced Circulatory Systems, Inc.; ResQPOD® Circulatory Enhancer: Strengthening the Chain of Survival (#49-0336-000, 01) [Brochure]; 2006; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Circulatory Enhancer: Strengthening the Chain of Survival (#49-0336-000, 02) [Brochure]; 2006; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; Introducing ResQPOD® (#49-0324-000; 01) [Brochure]; 2005; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 03) [Brochure]; 2010; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Impedance Threshold Device 10.0: Strengthening the Chain of Survival (#49-0336-000, 03) [Brochure]; 2009; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 02) [Brochure]; 2009; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Impedance Threshold Device: Strengthening the Chain of Survivial (#49-0336-000, 04) [Brochure]; 2010; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Impedance Threshold Device: Strengthening the Chain of Survival (#49-0336-000, 05) [Brochure] 2010; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 04) [Brochure]; 2011; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® Perfusion on Demand: ResQPOD Impedance Threshold Device (#49-0324-001, 05) [Brochure] 2011; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; ResQPOD® ITD: Stengthening the Chain of Survivial (#49-0336-000, 06) [Brochure]; 2011; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; Early Intervention is Life-Saving in Cardiac Arrest (#49-0864-000-01) [Brochure]; Aug. 2011; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; Early Intervention is Life-Saving in Cardiac Arrest (#49-0864-000-02) [Brochure]; Aug. 2011; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; Benefits of the ResQPOD Based Upon the ROC PRIMED Study (#49-0864-000-03) [Brochure]; Jan. 2012; 2 pages; Roseville, MN. |
Advanced Circulatory Systems, Inc.; Benefits of ResQPOD Based Upon the ROC PRIMED Study (#49-0864-000, 04) [Brochure]; Mar. 2012; 2 pages; Roseville, MN. |
AMBU International A/S; Directions for use of Ambu® CardioPump™; 8 pages. |
Aufderheide et al.; Hyperventilation-induced hypotension during cardiopulmonary resuscitation; Circulation; 2004; pp. 1960-1965; vol. 109; No. 16. |
Aufderheide et al.; Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: A randomized trial; Lancet; 2011, pp. 301-311, vol. 377. |
Christenson; Abdominal Compressions During CPR: Hemodynamic Effects of Altering Timing and Force; The Journal of Emergency Medicine; 1992; pp. 257-266; vol. 10. |
Cohen et al.; Active-Compression-Decompression: A Novel Method of Cardiopulmonary Resuscitation; American Heart Journal; 1992; pp. 1145-1150; vol. 126; No. 5. |
Cohen et al.; Active Compression-Decompression: A New Method of Cardiopulmonary Resuscitations; The Journal of the American Medical Association; Jun. 3, 1992; pp. 2916-2923; vol. 267; No. 21. |
Dupuis; Ventilators: Theory and Clinical Application; Jan. 1986; 7 pages; Mosby Company. |
Geddes et al.; Electrically Produced Artificial Ventilation; Medical Instrumentation; 1988; pp. 263-271; vol. 22; No. 5. |
Geddes et al.; Optimum Stimulus Frequency for Contracting the Inspiratory Muscles with Chest-Surface Electrodes to Produce Artificial Respiration; Annals of Biomedical Engineering; 1990; pp. 103-108; vol. 18. |
Geddes et al.; Inspiration Produced by Bilateral Electromagnetic, Cervical Phrenic Nerve Stimulation in Man; IEEE Transactions on Biomedical Engineering; Oct. 1991; pp. 1047-1048; vol. 38; No. 9. |
Geddes et al.; Electroventilation—A Missed Opportunity?; Biomedical Instrumentation & Technology; 1998; pp. 401-414; vol. 32. |
Glenn et al.; Diaphragm Pacing by Electrical Stimulation of the Phrenic Nerve; Neurosurgery; 1985; pp. 974-984; vol. 17; No. 6. |
Glenn et al.; Twenty Years of Experience in Phrenic Nerve Stimulation to Pace the Diaphragm; PACE; 1986; pp. 780-784; vol. 9. |
International Search Report and Written Opinion of PCT/US2004/027772; mailed on Mar. 11, 2005; 5 pages. |
International Search Report and Written Opinion of PCT/US2008/060367; mailed on Sep. 23, 2008; 11 pages. |
Kotze et al.; Diaphragm Pacing in the Treatment of Ventilatory Failure; San Deel; Aug. 17, 1995; pp. 223-224; vol. 68. |
Laghi et al.; Comparison of Magnetic and Electrical Phrenic Nerve Stimulation in Assessment of Diaphragmatic Contractility; American Physiological Society; 1996; pp. 1731-1742. |
Lindner et al.; Effects of Active Compression-Decompression Resuscitation of Myocardial and Cerebral Blood Flow in Pigs; Department of Anesthesiology and Critical Care Medicine; University of Ulm, Germany; Oct. 7, 1993; pp. 1254-1263; vol. 88; No. 3. |
Lurie et al.; Regulated to Death: The Matter of Informed Consent for Human Experimentation in Emergency Resuscitation Research; Cardiac Arrhythmia Center at the University of Minnesota; PACE; Jul. 1995; pp. 1443-1447; vol. 18. |
Mushin et al.; Automated Ventilation of the Lungs—The Lewis-Leigh Inflating Valve; Blackwell Scientfic; p. 838; Oxford, UK. |
Search Report of AU 2008243018; mailed on Sep. 18, 2012; 3 pages. |
Segal, et al.; Ischemic Postconditioning at the Initiation of Cardiopulmonary Resuscitation Facilitates Cardiac and Cerebral Recovery After Prolonged Untreated Ventricular Fibrillation; Resuscitation; 2012; 7 pages. |
Supplementary Partial European Search Report for European Patent Application No. EP 08745882 (PCT/US2008/060367); mailed on Feb. 26, 2014; 8 pages. |
Yannopoulos, et al; Intrathoracic Pressure Regulator During Continuous-Chest-Compression Advanced Cardiac Resuscitation Improves Vital Organ Perfusion Pressures in a Porcine Model of Cardiac Arrest; Circulation; 2005; pp. 803-811. |
Yannopoulos et al.; Intrathoracic pressure regulation improves vital organ perfusionn pressures in normovolemic and hypovolemic pigs; Resuscitation; 2006; pp. 445-453; vol. 70. |
Yannopoulos et al., Intrathoracic Pressure Regulation Improves 24-Hour Survival in a Porcine Model of Hypovolemic Shock; Anesthesia & Analgesia; ITPR and Survival in Hypovolemic Shock; 2007; pp. 157-162; vol. 104; No. 1. |
Yannopoulos et al.; Sodium nitroprusside enhanced cardiopulmonary resuscitation improves survival with good neurological function in a porcine model of prolonged cardiac arrest; Critical Care Medicine; 2011; 6 pages; vol. 39; No. 6. |
Yannopoulos et al.; Controlled pauses at the initiation of sodium nitroprusside-enhanced cardiopulmonary resuscitation facilitate neurological and cardiac recovery after 15 minutes of untreated ventricular fibrillation; Critical Care Medicine; 2012; 8 pages; vol. 40, No. 5. |
Advanced Circulatory Systems, Inc. (Jan. 2014), Emerging Data: The Resuscitation Outcomes Consortium (ROC) PRIMED Study on the Efficacy of the ITD (#49-0864-000,06) [Brochure], Roseville, MN:Advanced Circulatory Systems, Inc. 2 pages. |
Advanced Circulatory Systems, Inc. (Jan. 2013), Emerging Data: The Resuscitation Outcomes Consortium (ROC) Primed Study on the Efficacy of the ITD (#49-0864-000,05) [Brochure], Roseville, MN:Advanced Circulatory Systems, Inc. 2 pages. |
Advanced Circulatory Systems, Inc. (2013), ResQPOD More than a Heartbeat (#49-0336-000,08) [Brochure], Roseville, MN:Advanced Circulatory Systems, Inc. 2 pages. |
Babbs, Charles F.MD. PhD., CPR Techniques that Combine Chest and AbdominalCompression and Decompression: Hemodynamic Insights from a Spreadsheet Model, Circulation,1999, pp. 2146-2152. |
Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care, JAMA, 1992:268; 5 pages. |
Lurie, K., et. al., Comparison of a 10-Breaths-Per-Minute Versus a 2-Breaths-Per-Minute Strategy During Cardiopulmonary Resuscitation in a Porcine Model of Cardiac Arrest,: Respiratory Care, 2008, vol. 53, No. 7, pp. 362-870. |
Michigan Instruments, Inc.Thumper 1007CC Continuous Compression Cardiopulmonary Resuscitation System, obtained online Jul. 15, 2006 at http://WwW.michiganinstruments.com/resus-thumper.htm, 2 pages. |
Schultz, J., et al., “Sodium nitroprusside enhanced cardiopulmonary resuscitation (SNPeCPR) improves vitalorgan perfusion pressures and carotid blood flow in a porcine modelof cardiac arrest,” Resuscitation, 2012, vol. 83, pp. 374-377. |
Shapiro et al., “Neurosurgical Anesthesia and Intracranial Hypertension” Chapter 54, Anesthesia; 3rd Edition; Ed. Ron Miller 1990. |
Zhao et. al., Inhibation of a Myocardial Injury by Ischemic Postconditioning During RePerfusion:Comparison with Ischemic Preconditioning, Am. J. Physiol Heart Circ 285: H579-H588 (2003). |
Zoll Autopulse Non-Invasive Cardiac Support Pump, obtained online on Jul. 15, 2006 at http://www.zoll.com/product.aspx?id=84,1 page. |
Number | Date | Country | |
---|---|---|---|
20150202393 A1 | Jul 2015 | US |
Number | Date | Country | |
---|---|---|---|
60912891 | Apr 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13411230 | Mar 2012 | US |
Child | 14635525 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11871879 | Oct 2007 | US |
Child | 13411230 | US |